Security Snapshot

Nuvation Bio Inc. - Common Stock (NUVB) Institutional Ownership

CUSIP: 67080N101

13F Institutional Holders and Ownership History from Q1 2021 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

221

Shares (Excl. Options)

211,328,474

Price

$8.96

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
NUVB on NYSE
Shares outstanding
339,200,672
Price per share
$4.29
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
211,328,474
Total reported value
$1,893,137,504
% of total 13F portfolios
0.01%
Share change
-12,204,164
Value change
-$57,998,696
Number of holders
221
Price from insider filings
$4.29
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • NUVB - Nuvation Bio Inc. - Common Stock is tracked under CUSIP 67080N101.
  • 221 institutions reported positions in Q4 2025.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 221 to 20 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,893,137,504 to $4,975,058.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 221 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 67080N101?
CUSIP 67080N101 identifies NUVB - Nuvation Bio Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Nuvation Bio Inc. - Common Stock (NUVB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +11% $110,306,310 +$11,583,764 50,599,225 +12% FMR LLC 31 Mar 2025
BlackRock, Inc. 6.4% +30% $42,332,244 +$10,273,842 21,708,843 +32% BlackRock, Inc. 30 Jun 2025

As of 31 Dec 2025, 221 institutional investors reported holding 211,328,474 shares of Nuvation Bio Inc. - Common Stock (NUVB). This represents 62% of the company’s total 339,200,672 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Nuvation Bio Inc. - Common Stock (NUVB) together control 54% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 15% 51,424,981 +1.7% 0.02% $460,767,830
Decheng Capital LLC 7.7% 25,954,439 0% 31% $232,551,773
BlackRock, Inc. 7.3% 24,669,776 +0.27% 0% $221,041,196
VANGUARD GROUP INC 4.6% 15,555,606 +0.65% 0% $139,378,229
Omega Fund Management, LLC 2.4% 8,081,089 -8.5% 25% $72,406,557
Laurion Capital Management LP 2.3% 7,852,638 -19% 4.8% $70,359,636
STATE STREET CORP 1.7% 5,858,782 -3.8% 0% $52,494,687
GEODE CAPITAL MANAGEMENT, LLC 1.7% 5,712,296 -3% 0% $51,191,720
TANG CAPITAL MANAGEMENT LLC 1.1% 3,857,457 -8.2% 1.7% $34,562,815
ABRAMS CAPITAL MANAGEMENT, L.P. 1.1% 3,811,513 0% 0.6% $34,151,156
BANK OF AMERICA CORP /DE/ 1.1% 3,809,425 +505% 0% $34,132,448
Redmile Group, LLC 0.93% 3,163,256 +4.4% 2.1% $28,342,774
Nuveen, LLC 0.84% 2,852,001 -38% 0.01% $25,553,930
PRICE T ROWE ASSOCIATES INC /MD/ 0.8% 2,708,553 +852% 0% $24,270,000
DIMENSIONAL FUND ADVISORS LP 0.61% 2,066,360 -38% 0% $18,514,586
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.59% 2,016,681 -1.9% 0% $18,069,462
NORTHERN TRUST CORP 0.57% 1,921,732 -9.3% 0% $17,218,719
GOLDMAN SACHS GROUP INC 0.5% 1,696,013 +41% 0% $15,196,276
AQR CAPITAL MANAGEMENT LLC 0.49% 1,669,166 -18% 0.01% $14,955,727
Capricorn Fund Managers Ltd 0.47% 1,588,854 3.4% $14,236,132
Knoll Capital Management, LLC 0.44% 1,498,591 +46% 6.2% $13,427,375
Qube Research & Technologies Ltd 0.38% 1,280,899 0.02% $11,476,855
MORGAN STANLEY 0.38% 1,276,128 -3.3% 0% $11,434,107
ARMISTICE CAPITAL, LLC 0.37% 1,263,737 -45% 0.28% $11,323,084
SymBiosis Capital Partners, LLC 0.37% 1,250,000 0% 12% $11,200,000

Institutional Holders of Nuvation Bio Inc. - Common Stock (NUVB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 1,157,466 $4,975,058 +$830,251 $4.29 20
2025 Q4 211,328,474 $1,893,137,504 -$57,998,696 $8.96 221
2025 Q3 220,537,335 $817,798,856 -$1,495,817 $3.70 201
2025 Q2 224,729,650 $439,155,420 +$34,613,471 $1.95 179
2025 Q1 207,335,118 $364,911,263 +$18,852,443 $1.76 159
2024 Q4 197,748,566 $526,027,669 +$38,581,638 $2.66 159
2024 Q3 187,137,100 $428,593,958 +$73,128,321 $2.29 153
2024 Q2 153,048,262 $446,948,909 +$52,594,408 $2.92 146
2024 Q1 134,652,746 $490,113,918 +$5,142,866 $3.64 122
2023 Q4 134,270,272 $202,718,680 -$2,287,216 $1.51 116
2023 Q3 136,892,011 $183,439,434 -$9,239,486 $1.34 122
2023 Q2 139,011,387 $250,194,724 +$3,219,600 $1.80 120
2023 Q1 137,479,282 $228,214,660 -$4,709,474 $1.66 126
2022 Q4 139,580,600 $267,992,788 -$12,224,298 $1.92 123
2022 Q3 141,780,239 $317,588,133 -$44,323,294 $2.24 116
2022 Q2 155,298,098 $503,167,223 -$21,514,875 $3.24 116
2022 Q1 159,104,350 $836,898,347 +$14,198,236 $5.26 112
2021 Q4 155,258,449 $1,319,350,594 +$21,011,876 $8.50 103
2021 Q3 151,280,175 $1,503,381,648 +$33,688,697 $9.94 97
2021 Q2 147,981,823 $1,364,632,796 +$15,849,184 $9.31 97
2021 Q1 145,559,447 $1,478,100,000 +$1,473,836,329 $10.45 72